世界の降圧薬市場2020-2027:治療クラス別(利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他)、流通経路別、地域別

◆英語タイトル:Global Antihypertensive Drugs Market Size study, by Therapeutic Class (Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027
◆商品コード:BZW20PL013
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年8月7日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥656,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、降圧薬の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、治療クラス別(利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他)分析、流通経路別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・降圧薬の世界市場規模:治療クラス別(利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他)
・降圧薬の世界市場規模:流通経路別
・降圧薬の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Antihypertensive Drugs Market is valued at approximately USD 23.2 million in 2019 and is anticipated to grow with a healthy growth rate of more than 3.1% over the forecast period 2020-2027. Antihypertensive drug is the class of drug used in the treatment of hypertension (high blood pressure). Hypertension is one of the leading causes of heart complications, such as heart failure, heart attack, and dementia. Thus, the treatment of hypertension must be integrated into an overall program to manage factors that intensify the risk of cardiovascular events (such as stroke and myocardial infarction). Therefore, there are a variety of antihypertensive drugs has been developed for treating hypertension. Some of the major antihypertensive drugs are thiazide diuretics, beta-adrenoceptor antagonists (beta-blockers), dihydropyridine calcium-channel blockers, and many more. These drugs can reduce the blood pressure rates and can prevent the health complications associated with high blood pressure. Therefore, these factors are anticipated to accelerate the market growth around the world. Moreover, the rise in cases of hypertension across the globe, followed by the growing elderly population are few other factors responsible for the market growth over the forecast period. According to the World Health Organization (WHO), around 1.3 billion people have hypertension around the world. Also, the possibility of its prevalence increases with age. As per the Framingham Heart Study, hypertension eventually developed in over 90% of participants with normal blood pressure at 55 years of age. By age 60 years of age, nearly 60% of the population has hypertension, by 70 years, about 65% of men and 75% of women have hypertension. This, in turn, is likely to accelerate the demand for drugs all over the world. Recently, the COVID-19 is widely spread throughout the world, thus various regional governments are mandating the use of drugs among the patients to prevent or mitigate the risk of respiratory-related problems. This is likely to strengthen the usage for antihypertensive drugs that encourage the manufacturers to produce them thereby, the market would grow at a significant rate in the forthcoming years. However, side-effects related to the use of drugs is one of the major factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Antihypertensive Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to rise in prevalence of hypertension, along with the significant initiatives opt by the market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising geriatric population and increasing incidences of heart attack and failures among people would create lucrative growth prospects for the Antihypertensive Drugs market across the Asia-Pacific region.

Major market player included in this report are:
Boehringer Ingelheim International GmbH
Merck & Co., KGaA
Johnson and Johnson
Bayer AG
Pfizer, Inc.
Takeda Pharmaceutical Co. Ltd.
AstraZeneca plc
Daiichi Sankyo Company, Ltd.
Sanofi S.A.
Novartis International AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutic Class:
Diuretics
Angiotensin-Converting Enzyme (ACE) Inhibitors
Calcium Channel Blockers
Vasodilators
Beta-adrenergic Blockers
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Antihypertensive Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. Antihypertensive Drugs Market, by Region, 2018-2027 (USD Million)
1.2.2. Antihypertensive Drugs Market, by Therapeutic Class, 2018-2027 (USD Million)
1.2.3. Antihypertensive Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antihypertensive Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antihypertensive Drugs Market Dynamics
3.1. Antihypertensive Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Antihypertensive Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antihypertensive Drugs Market, by Therapeutic Class
5.1. Market Snapshot
5.2. Global Antihypertensive Drugs Market by Therapeutic Class, Performance – Potential Analysis
5.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Therapeutic Class 2017-2027 (USD Million)
5.4. Antihypertensive Drugs Market, Sub Segment Analysis
5.4.1. Diuretics
5.4.2. Angiotensin-Converting Enzyme (ACE) Inhibitors
5.4.3. Calcium Channel Blockers
5.4.4. Vasodilators
5.4.5. Beta-adrenergic Blockers
5.4.6. Others
Chapter 6. Global Antihypertensive Drugs Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Antihypertensive Drugs Market by Distribution Channel, Performance – Potential Analysis
6.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Million)
6.4. Antihypertensive Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
Chapter 7. Global Antihypertensive Drugs Market, Regional Analysis
7.1. Antihypertensive Drugs Market, Regional Market Snapshot
7.2. North America Antihypertensive Drugs Market
7.2.1. U.S. Antihypertensive Drugs Market
7.2.1.1. Therapeutic Class breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Antihypertensive Drugs Market
7.3. Europe Antihypertensive Drugs Market Snapshot
7.3.1. U.K. Antihypertensive Drugs Market
7.3.2. Germany Antihypertensive Drugs Market
7.3.3. France Antihypertensive Drugs Market
7.3.4. Spain Antihypertensive Drugs Market
7.3.5. Italy Antihypertensive Drugs Market
7.3.6. Rest of Europe Antihypertensive Drugs Market
7.4. Asia-Pacific Antihypertensive Drugs Market Snapshot
7.4.1. China Antihypertensive Drugs Market
7.4.2. India Antihypertensive Drugs Market
7.4.3. Japan Antihypertensive Drugs Market
7.4.4. Australia Antihypertensive Drugs Market
7.4.5. South Korea Antihypertensive Drugs Market
7.4.6. Rest of Asia Pacific Antihypertensive Drugs Market
7.5. Latin America Antihypertensive Drugs Market Snapshot
7.5.1. Brazil Antihypertensive Drugs Market
7.5.2. Mexico Antihypertensive Drugs Market
7.6. Rest of The World Antihypertensive Drugs Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Boehringer Ingelheim International GmbH
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Merck & Co., KGaA
8.2.3. Johnson and Johnson
8.2.4. Bayer AG
8.2.5. Pfizer, Inc.
8.2.6. Takeda Pharmaceutical Co. Ltd.
8.2.7. AstraZeneca plc
8.2.8. Daiichi Sankyo Company, Ltd.
8.2.9. Sanofi S.A.
8.2.10. Novartis International AG
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

TABLE 1. Global Helmet market, report scope
TABLE 2. Global Helmet market estimates & forecasts by Region 2017-2027 (USD Billion)
TABLE 3. Global Helmet market estimates & forecasts by Type 2017-2027 (USD Billion)
TABLE 4. Global Helmet market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Helmet market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Helmet market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Helmet market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Helmet market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Helmet market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Helmet market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Helmet market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Helmet market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Helmet market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Helmet market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. U.S. Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. U.S. Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 17. U.S. Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 18. Canada Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Canada Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 20. Canada Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 21. UK Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. UK Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. UK Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Germany Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Germany Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Germany Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. RoE Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. RoE Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. RoE Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. China Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. China Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. China Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. India Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. India Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. India Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Japan Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Japan Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Japan Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. RoAPAC Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. RoAPAC Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. RoAPAC Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. Brazil Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. Brazil Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. Brazil Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. Mexico Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. Mexico Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. Mexico Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. RoLA Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. RoLA Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. RoLA Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Row Helmet market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Row Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Row Helmet market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Helmet market
TABLE 55. List of primary sources, used in the study of global Helmet market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

FIG 1. Global Helmet market, research methodology
FIG 2. Global Helmet market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Helmet market, key trends 2019
FIG 5. Global Helmet market, growth prospects 2020-2027
FIG 6. Global Helmet market, porters 5 force model
FIG 7. Global Helmet market, pest analysis
FIG 8. Global Helmet market, value chain analysis
FIG 9. Global Helmet market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Helmet market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Helmet market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Helmet market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Helmet market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Helmet market, regional snapshot 2017 & 2027
FIG 15. North America Helmet market 2017 & 2027 (USD Billion)
FIG 16. Europe Helmet market 2017 & 2027 (USD Billion)
FIG 17. Asia pacific Helmet market 2017 & 2027 (USD Billion)
FIG 18. Latin America Helmet market 2017 & 2027 (USD Billion)
FIG 19. Global Helmet market, company market share analysis (2019)






【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の降圧薬市場2020-2027:治療クラス別(利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他)、流通経路別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆